DE2025095A1 - Makroaggregate von Kupfer 64 und Gelatine sowie Verfahren zur Herstellung und Verwendung derselben - Google Patents

Makroaggregate von Kupfer 64 und Gelatine sowie Verfahren zur Herstellung und Verwendung derselben

Info

Publication number
DE2025095A1
DE2025095A1 DE19702025095 DE2025095A DE2025095A1 DE 2025095 A1 DE2025095 A1 DE 2025095A1 DE 19702025095 DE19702025095 DE 19702025095 DE 2025095 A DE2025095 A DE 2025095A DE 2025095 A1 DE2025095 A1 DE 2025095A1
Authority
DE
Germany
Prior art keywords
copper
gelatin
solution
macro
aggregates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19702025095
Other languages
German (de)
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Commissariat a lEnergie Atomique et aux Energies Alternatives CEA
Original Assignee
Commissariat a lEnergie Atomique CEA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Commissariat a lEnergie Atomique CEA filed Critical Commissariat a lEnergie Atomique CEA
Publication of DE2025095A1 publication Critical patent/DE2025095A1/de
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1217—Dispersions, suspensions, colloids, emulsions, e.g. perfluorinated emulsion, sols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1241—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins
    • A61K51/1244—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins microparticles or nanoparticles, e.g. polymeric nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Nanotechnology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE19702025095 1969-05-28 1970-05-22 Makroaggregate von Kupfer 64 und Gelatine sowie Verfahren zur Herstellung und Verwendung derselben Pending DE2025095A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR6917455A FR2043487A1 (https=) 1969-05-28 1969-05-28

Publications (1)

Publication Number Publication Date
DE2025095A1 true DE2025095A1 (de) 1970-12-03

Family

ID=9034721

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19702025095 Pending DE2025095A1 (de) 1969-05-28 1970-05-22 Makroaggregate von Kupfer 64 und Gelatine sowie Verfahren zur Herstellung und Verwendung derselben

Country Status (5)

Country Link
US (1) US3743712A (https=)
BE (1) BE750785A (https=)
DE (1) DE2025095A1 (https=)
FR (1) FR2043487A1 (https=)
GB (1) GB1276205A (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4756904A (en) * 1986-06-05 1988-07-12 Oak Ridge Associated Universities, Inc. Method of imaging the heart using copper-64 citrate
PE20090186A1 (es) * 2007-03-23 2009-03-20 Novartis Ag Composicion farmaceutica que comprende una sal de cobre recubierta o encapsulada
EP1974733A1 (en) * 2007-03-23 2008-10-01 Novartis AG Use of a masked or coated copper salt for the treatment of macular degeneration

Also Published As

Publication number Publication date
GB1276205A (en) 1972-06-01
BE750785A (fr) 1970-11-03
US3743712A (en) 1973-07-03
FR2043487A1 (https=) 1971-02-19

Similar Documents

Publication Publication Date Title
DE2314059A1 (de) Verbesserte substanz fuer das markieren mit technetium-99m sowie verfahren zu deren herstellung
CH414063A (de) Röntgenkontrastmittel
DE69630727T2 (de) Radioaktiven Chitosankomplex und deren Anwendung in Strahlungstherapie
DE1951769A1 (de) Pharmazeutische Suspension und Stabilisierungsverfahren
DE2025095A1 (de) Makroaggregate von Kupfer 64 und Gelatine sowie Verfahren zur Herstellung und Verwendung derselben
DE69002627T2 (de) 99 m Tc (III) herzmuskelbildende Mittel, wirksam beim Menschen.
DE92993T1 (de) Zusammensetzung und verfahren zur untersuchung von alimentaerfunktionen.
DE2103387B2 (de) Verwendung des Hydrochlorids von Glukosamin zur Herstellung von pharmazeutischen Präparaten
Anghileri et al. New colloidal chromic radiophosphate (P32) for local irradiation of the central nervous system
DE2242395A1 (de) Radionuclid-generator und verfahren zu dessen herstellung
DE2621311C3 (de) Verfahren zum Herstellen von mittels Technetium 99↑m↑ markierten Proteinen
EP0003041B1 (de) Technetium-99m-markiertes Diagnostikum zur Darstellung des retikuloendothelialen Systems (RES) und Verfahren zu seiner Herstellung
DE2427659C3 (de) Verfahren zur Herstellung von radioaktiv markierten Erythrozyten
DE2140177A1 (de) Oral applizierbare, radioaktives jod enthaltende kapsel zur schilddruesenfunktionsdiagnostik und verfahren zu ihrer herstellung
DE1932231A1 (de) Diagnostisches und therapeutisches Praeparat auf der Basis eines chelatgebundenen Radio-Nuclids
DE2536008C3 (de) Verfahren zur Herstellung von zur Bindung von Technetium geeigneten zinnhaltigen Humanserumalbumin-Partikeln
DE3216026A1 (de) Technetium(99m)-markiertes isonicotinsaeurehydrazid, verfahren zu dessen herstellung und ein pharmazeutisches mittel, das diese verbindung enthaelt
DE3428265A1 (de) Acrylsaeurepolymerisat-haltiges mittel fuer die diagnostik des duodenums und des duenndarms
DE2124751A1 (de) Verfahren zur Herstellung eines diagnostischen Präparats auf Basis eines mit 99mTc markierten Eisenkomplexes
DE1292646B (de) 2-Alkyl-3, 3-diphenylacrylsaeuren, deren Alkalisalze und ein Verfahren zu deren Herstellung
DE678948C (de) Kontrastmittel fuer die Sichtbarmachung des Urogenitalsystems durch Roentgenstrahlen
CH625126A5 (en) Process for the production of tin-containing human serum albumin particles suitable for binding technetium
DE3402348C2 (https=)
DE2245826C3 (de) Salze von N-Cyano-äthyl-N'-m-chlorphenyl-piperazin
DE1810343A1 (de) Neue Adamantylidenverbindungen